Aakash K Hindocha Recommends Top Stocks for September 17, 2026

Aakash K Hindocha, Vice President - Research at Nuvama Professional Clients Group/Nuvama Wealth, has identified three top stocks to buy for September 17, 2026. The recommendations include Aegis Logistics, Aarti Pharmalabs, and Just Dial.

According to Hindocha, Aegis Logistics (BUY) is expected to outperform the broader market with a strong run when the broader market gets strength. The stock has taken a vital support at 20 DMA and can achieve an 8-10% rally in a short period of time with 20 DMA as trailing pause loss on a closing basis.

Aarti Pharmalabs (BUY) is also recommended, with Hindocha citing strong reversal candle and volume-led reversals. The stock has taken support at the 10-period moving average, showing underlying momentum on a higher timeframe.

Read More: India Completes Dedicated Freight Corridor Network, Boosts Rail Efficiency

Just Dial (BUY) is another top pick. With Hindocha noting that the stock respected its swing low and closed above previous session's high. A close above 680 level can lead to a strong rally of 8-10% in upcoming weeks.

Nifty is currently holding onto its vital support zone of 23150-23200, with charts reaching the oversold zone. A closing below the same would open gates for 22800-650 level.

However, a close above 23380 level would open targets for 23700-23850 level. Nifty is expected to hold onto its vital support zone and potentially return sideways to positive over the next month based on historical data.

Also Read: FPIs Pull Out Rs 13,138 Crore in September Amid Global Uncertainty and Rising Oil Prices

Bank Nifty has held onto its vital swing zone of 55700 and managed to reverse from the same. In yesterday's trading session, bank nifty outperformed Nifty and managed to lift the same.

Going forward, if yesterday's low holds, a test of 200 DMA at the 57300-500 zone cannot be ruled out.

Disclaimer: Recommendations and views on the stock market or any other asset classes or personal finance management tips given by experts and analysts are their own. These opinions do not represent the views of The Times of India.